Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorPeralta-Garcia, Alejandro
dc.contributor.authorTorrens-Fontanals, Mariona
dc.contributor.authorStepniewski, Tomasz Maciej
dc.contributor.authorGrau Exposito, Judit
dc.contributor.authorPerea Pérez, David
dc.contributor.authorAyinampudi, Vikram
dc.contributor.authorBuzón Gómez, María José
dc.contributor.authorGenesca Ferrer, Meritxell
dc.date.accessioned2022-06-15T11:45:19Z
dc.date.available2022-06-15T11:45:19Z
dc.date.issued2021-12
dc.identifier.citationPeralta-Garcia A, Torrens-Fontanals M, Stepniewski TM, Grau-Expósito J, Perea D, Ayinampudi V, et al. Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells. Int J Mol Sci. 2021 Dec;22(24):13592.
dc.identifier.issn1422-0067
dc.identifier.urihttp://hdl.handle.net/11351/7684
dc.descriptionCOVID-19; Reutilització de medicaments; Assajos d'entrada de cèl·lules virals
dc.description.sponsorshipThis research was funded by the Spanish Ministry of Science, Innovation, and Universities (FPU16/01209 to M.T.-F.); the Health department of the Government of Catalonia (DGRIS 3_9 to A.P.G. and J.S. and DGRIS 1_5 to M.J.B. and M.G.).
dc.language.isoeng
dc.publisherMDPI
dc.relation.ispartofseriesInternational Journal of Molecular Sciences;22(24)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectMedicaments antivírics
dc.subjectCOVID-19 (Malaltia)
dc.subjectMedicaments - Ús
dc.subject.meshAntiviral Agents
dc.subject.mesh/pharmacology
dc.subject.meshDrug Repositioning
dc.subject.meshCoronavirus Infections
dc.titleEntrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.3390/ijms222413592
dc.subject.decsantivíricos
dc.subject.decs/farmacología
dc.subject.decsnuevas indicaciones de medicamentos
dc.subject.decsinfecciones por Coronavirus
dc.relation.publishversionhttps://doi.org/10.3390/ijms222413592
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Peralta-Garcia A, Torrens-Fontanals M] Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University (UPF), 08003 Barcelona, Spain. [Stepniewski TM] Research Programme on Biomedical Informatics (GRIB), Department of Experimental and Health Sciences, Hospital del Mar Medical Research Institute (IMIM), Pompeu Fabra University (UPF), 08003 Barcelona, Spain. InterAx Biotech AG, PARK InnovAARE, 5234 Villigen, Switzerland. [Grau-Expósito J, Perea D, Buzón MJ, Genescà M] Servei de Malalties Infeccioses, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. [Ayinampudi V] InterAx Biotech AG, PARK InnovAARE, 5234 Villigen, Switzerland
dc.identifier.pmid34948390
dc.identifier.wos000737887800001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple